All times displayed for Europe/Berlin timezone.

Pharma Insight Briefings

The Future of Medicine: What are the therapies of tomorrow?
10:30 - 11:40 61D61
CPhI Theatre
Senior Consultant
Chief Development Officer
President & Co-Founder
Camargo Pharmaceutical Services

Oncology, auto-immune, cardiovascular, pulmonary and mental health are all key therapy areas for Pharma companies to crack. This panel will examine emerging therapies for the future pharma toolkit – both developing the new and repurposing the old.
• Value added medicines - Innovation through repurposing, and reformulating.
• New-gen APIs
• Personalised therapies
• The shift from mass market to niche therapies
• Balancing the needs of patients and payers
• What does the future hold for generics?

Exploring Trends in Contract Manufacturing
10:30 - 11:40 120D40
ICSE Theatre
xCell Strategic Consulting
President & CSO
Pharmatech Associates
Senior Vice President, Global Business Development & Marketing
Catalent Pharma Solutions
Executive Director
Patheon, part of Thermo Fischer Scientific
Founder & Former President
Editor in Chief
PharmSource – a GlobalData Product

As Pharma evolves towards more complex therapies with specific manufacturing needs, the role of the CDMO has never been so important. With efficiency, cost, flexibility and quality all essential components of outsourcing, how are CDMOs evolving to remain competitive? Which technologies and strategies will provide the biggest returns?
• Is the One Stop Shop concept dead?
• Continuous manufacturing – application & development factors
• Scalable facilities for flexible manufacture
• M&A and industry consolidation -how is this shaping the industry?

Trends in Sustainable pharma Packaging & Drug Delivery Devices
10:30 - 11:40 110D40
Pharmapack & InnoPack Theatre
Managing Director
Pharmacentric Solutions
Sustainability and Strategic Innovation Director
Huhtamaki Flexible Packaging
Research & Innovation Manager
Berry Global
Eco-Design Manager

BioProduction - Free to attend content

Training Workshop: An introduction to biopharmaceutical processing, current strategies and future landscape
10:30 - 11:40 120F38
BioProduction Theatre

• Understanding the fundamental differences between pharmaceuticals and biopharmaceuticals with a focus on emerging product classes
• Outline the major process steps involved in production of a biopharmaceutical product using antibodies as a case study
• Understand the importance of modified mammalian cells in protein/antibody production
• Appreciate the current trends and future drivers within the biopharmaceutical manufacturing landscape

Speaker: John Milne, Training Director, NIBRT, Ireland

Panel Discussion: Challenges, benefits and implementation strategies for process intensification and continuous processing
11:50 - 12:20 120F38
BioProduction Theatre
Panel Discussion: Adapting manufacturing strategies and facilities to next generation biotherapeutics and emerging therapies
12:30 - 13:00 120F38
BioProduction Theatre

• Aranzazu Lera, Head of Architecture, PM Group, UK
• Peter Wojciechowski, Head Drug Substance Process Development, Moderna Therapeutics, USA
• Nripen Singh, Associate Director, MS&T Downstream, Bristol-Myers Squibb, USA

Panel Discussion: Manufacturing and commercialisation of cell and gene therapies
13:10 - 13:40 120F38
BioProduction Theatre
Bioproduction Keynote Presentations: Bioproduction Plenary Stage- 120A02
13:50 - 15:00 120F38
BioProduction Theatre

• 14:00 - 14:30 Keynote Presentation: Today’s Challenges and Opportunities in Biomanufacturing
• 14:30 - 15:00 Keynote Presentation

• Judy Chou, Senior Vice President & Global Head of Biotech; Site Head of Bayer Berkeley CA USA, Bayer Pharmaceuticals
• GE Healthcare Representative

Spotlight Presentation: Available Slot
15:10 - 15:40 120F38
BioProduction Theatre

Please contact [email protected] for further details .

Spotlight Presentation: Available Slot
15:50 - 16:20 120F38
BioProduction Theatre

Please contact [email protected] for further details .


Panel discussion: Global Trends in Natural Extracts
11:00 - 12:00 41K01
Natural Extracts Podium
Chief Science Officer
American Herbal Products Association
Global Principal, Consumer Health R&D

• From consumer demand for naturals to meaningful innovation and benefits
• Clinical trials and Real-World Evidence as key elements to demonstrate the important role of naturals in health
• Innovation strategies for established natural products
• Holistic health concepts around naturals in combination with evolving

Brexit and the implications for Pharma – is it a deal or no deal?
11:45 - 12:30 80B10
World of Pharma Podium
Global Head & Executive Vice President of Healthcare Operations & Strategy
GlobalData PLC

It has been about three years since the UK voted to leave the EU. Businesses were told a vote to leave the EU would drive the UK into a severe recession, yet markets are up. Over the past 18 months, GlobalData has conducted a quarterly survey with pharmaceutical industry respondents in the UK, US and EU to better understand how their sentiment towards Brexit changed over time and how they expected Brexit to affect the healthcare sector, both within and outside of the UK. The majority of respondents indicate that “No Brexit” is the best outcome but few believe that it is likely. In this presentation, we will examine:
• Outcomes of Brexit – best and most likely outcomes
• Impact on research and manufacturing
• Changes in corporate strategy
• Likelihood of staff or headquarter relocation
• Evolving sentiment over the past 12-18 months

Curcumin - from Ayurveda to Clinical Trials
12:15 - 13:15 41K01
Natural Extracts Podium
Lunch Break
12:30 - 13:00 80B10
World of Pharma Podium
Regulatory Outlook & Trends
13:00 - 14:00 80B10
World of Pharma Podium
Africa and the Middle East - Still a promise or real business?
14:00 - 14:45 80B10
World of Pharma Podium
Managing Partner
Blending the Natural with the Chemical – Finding the balance between natural extracts and pharma
14:00 - 15:00 41K01
Natural Extracts Podium
Managing Director
Digital disruption is knocking – is healthcare ready?
14:45 - 15:30 80B10
World of Pharma Podium
Global Head & Executive Vice President of Healthcare Operations & Strategy
GlobalData PLC

The healthcare industry is preparing to ride the digital wave and advances in technology are beginning to have impact across the entire spectrum of the value chain, from the lab to the clinic and beyond. Supply chains are starting to evolve, as new players take on increasingly important roles. Drug and medical device manufacturers will continue to provide much of the equipment and consumables to healthcare providers. However, technology players such as manufacturers of medical sensors, wearable devices, and robots will play an increasingly important role. How key technologies such as AI, blockchain, biosensors, robotics and 3D printing will provide opportunities for healthcare in the near term?